China R&D Reader

Millipore Corporation, a leading life science company, and Merck & Co. Inc., a global pharmaceutical and chemicals company, entered into a definitive agreement under which Merck will acquire all outstanding shares of common stock of Millipore for US$107 per share in cash, or a total transaction value, including net debt, of approximately €5.3 billion (US$7.2 [...]

Pricing pressures, primarily for large-scale production of biologics is causing the typically North American and European industry to now include Asia.
The biopharmaceutical contract manufacturing industry has long been established in North America and Western Europe, where contractors have been producing biologic clinical trial material and commercial products for biotechnology companies for more than a decade. [...]

SGS Life Science Services, the  CRO division of Swiss testing firm SGS, expanded its microbiology testing laboratory in Shanghai, China to offer cGMP compliant API testing services for method development and validation.
The laboratory comprises 700 square metres of floor space and houses 27 full-time analytical staff. It offers current good manufacturing (cGMP) practice standard microbiology, stability and endotoxin [...]